IP Library Patent Application 13521818
Patent Application
App. No. 13/521,818

Multivalent Antibodies

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/521,818
Abstract

The present invention provides a recombinant antibody or a heavy/light chain component thereof comprising: a heavy chain comprising a C H1 constant region fragment located between a first and second variable domain, and a third variable domain linked directly or indirectly to the first or second variable domain, with the proviso that the heavy chain only contains one C H1 and only contains three variable domains, and a light chain comprising at least a C L domain located between a first and second variable domain, and a third variable domain linked directly or indirectly to the first or second variable domain, with the proviso that the light chain only contains one C L domain and only contains three variable domains, and wherein said heavy and light chains are aligned to provide a first binding site formed by the first variable domains in the light and heavy chain, a second binding site formed by the second variable domains in the light and heavy chain, and a third binding site formed by the third variable domains in the light and heavy chain.

Claims (25)

1 . A recombinant antibody or a heavy/light chain component thereof comprising:

a heavy chain comprising a C H1 constant region fragment located between a first and second variable domain, and a third variable domain linked directly or indirectly to the first or second variable domain,

with the proviso that the heavy chain only contains one C H1 and only contains three variable domains, and

a light chain comprising at least a C L domain located between a first and second variable domain, and a third variable domain linked directly or indirectly to the first or second variable domain,

with the proviso that the light chain only contains one C L domain and only contains three variable domains, and

wherein said heavy and light chains are aligned to provide a first binding site formed by the first variable domains in the light and heavy chain, a second binding site formed by the second variable domains in the light and heavy chain, and a third binding site formed by the third variable domains in the light and heavy chain.

2 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 wherein C H1 is fused to the first variable domain in the heavy chain.

3 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 wherein C L is fused to the first variable domain in the light chain.

4 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 , wherein C H1 is also linked directly or indirectly to the second variable domain in the heavy chain.

5 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 , wherein C L is also linked directly or indirectly to the second variable domain in the light chain.

6 . A recombinant antibody or a heavy/light chain component thereof according to claim 4 wherein the indirect link is a peptide linker.

7 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 , wherein the third variable domain is linked indirectly.

8 . A recombinant antibody or a heavy/light chain component thereof according to claim 7 wherein the indirect link is a peptide linker.

9 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 , wherein the third variable domain in the heavy and/or light chain is linked to the first variable domain therein.

10 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 , wherein the third variable domain in the heavy and/or light chain is linked to the second variable domain therein.

11 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 wherein each variable domain in the heavy chain is a VH domain and each variable domain in the light chain is a VL domain.

12 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 wherein each binding site is formed by a variable domain VH/VL pair which is a cognate pair.

13 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 wherein each binding site is formed by a variable domain VH/VL pair which are a complementary VH/VL pair which bind antigen co-operatively.

14 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 , wherein the variable domains of at least one binding site are linked by a disulfide bond.

15 . A recombinant antibody or heavy/light chain component thereof according to claim 1 wherein the second variable domains forming the second binding site are stabilized by a disulfide bond.

16 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 , wherein third variable domains forming the third binding site are stabilized by a disulfide bond.

17 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 , wherein the C H1 of the heavy chain is linked to the C L of the light chain by a disulfide bond.

18 . A recombinant protein according to claim 17 , where in C H1 does not comprise a hinge region.

19 . A recombinant antibody or a heavy/light chain component thereof according to claim 1 which is monospecific, bispecific or trispecific.

20 . A recombinant antibody or a heavy/light chain component thereof according to claim 5 wherein the indirect link is a peptide linker.

Assignments (2)
CONFIRMATORY ASSIGNMENT Recorded Jun 10, 2016
From: UCB PHARMA, S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 038953/0312 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2013
From: ADAMS, RALPH; DAVE, EMMA
To: UCB PHARMA S.A.
Reel/Frame 031528/0539 →